bf/NASDAQ:XBIT_icon.jpeg

COM:XBIOTECH

XBiotech

  • Stock

Last Close

6.62

22/11 21:00

Market Cap

208.20M

Beta: -

Volume Today

37.41K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-9.93M
-
-21.72M
118.84%
-37.48M
72.54%
-52.76M
40.76%
-33.15M
37.17%
-21.14M
36.24%
668.63M
3,263.16%
-11.22M
101.68%
-17.41M
55.19%
-32.90M
88.93%
-24.56M
25.36%
depreciation and amortization
784K
-
664K
15.31%
699K
5.27%
698K
0.14%
1.48M
112.61%
2.43M
63.95%
2.36M
2.96%
2.24M
5.21%
2.65M
18.32%
2.61M
1.28%
1.74M
33.28%
deferred income tax
-444K
-
-90K
79.73%
-90K
0%
-815K
805.56%
-59K
92.76%
stock based compensation
739K
-
7.02M
849.93%
4.41M
37.22%
5.57M
26.46%
1.75M
68.60%
1.66M
5.14%
3.36M
102.29%
12.58M
274.66%
4.46M
64.53%
5.06M
13.42%
3.26M
35.56%
change in working capital
-504K
-
2.34M
564.29%
-774K
133.08%
475K
161.37%
-4.13M
970.32%
508K
112.29%
-17.62M
3,568.11%
-68.75M
290.21%
79.75M
216.00%
7.60M
90.47%
2.72M
64.22%
accounts receivables
-4.11M
-
4.11M
200%
8.56M
108.02%
829K
90.31%
inventory
-57.53M
-
-2.50M
95.66%
-8.56M
242.65%
accounts payables
103K
-
1.07M
936.89%
840K
21.35%
-981K
216.79%
-2.70M
175.23%
-78K
97.11%
496K
735.90%
-334K
167.34%
-514K
53.89%
357K
169.46%
91K
74.51%
other working capital
-607K
-
1.27M
309.56%
-1.61M
226.89%
1.46M
190.21%
-1.43M
198.49%
586K
140.86%
-18.11M
3,191.13%
-6.76M
62.65%
78.65M
1,262.54%
7.24M
90.79%
1.80M
75.16%
other non cash items
-157K
-
401K
-
-674.56M
-
90K
100.01%
90K
0%
3.62M
3,916.67%
-1.83M
150.73%
net cash provided by operating activities
-8.91M
-
-11.70M
31.34%
-33.31M
184.68%
-46.02M
38.15%
-33.65M
26.87%
-16.54M
50.85%
-18.27M
10.48%
-65.15M
256.59%
69.44M
206.59%
-14.82M
121.35%
-18.73M
26.32%
investments in property plant and equipment
-59K
-
-1.40M
2,267.80%
-10.39M
643.88%
-13.91M
33.89%
-1.41M
89.90%
-122K
91.32%
-204K
67.21%
-3.73M
1,726.96%
-3.52M
5.42%
-585K
83.40%
-362K
38.12%
acquisitions net
675M
-
purchases of investments
-63.31M
-
sales maturities of investments
61.86M
-
other investing activites
net cash used for investing activites
-59K
-
-1.40M
2,267.80%
-10.39M
643.88%
-13.91M
33.89%
-1.41M
89.90%
-122K
91.32%
674.80M
553,211.48%
-3.73M
100.55%
-3.52M
5.42%
-63.89M
1,712.54%
61.50M
196.25%
debt repayment
common stock issued
75.71M
-
1.81M
97.61%
32.62M
1,704.20%
201K
99.38%
38.06M
18,836.32%
-420M
1,203.46%
-420M
0%
5K
-
common stock repurchased
-420M
-
dividends paid
-75.00M
-
other financing activites
12.04M
-
63.20M
424.70%
1.76M
97.22%
1.14M
35.38%
703K
38.12%
4.03M
-
430.28M
10,566.24%
428.00M
0.53%
-14K
-
net cash used provided by financing activities
12.04M
-
63.20M
424.70%
77.47M
22.58%
2.94M
96.20%
33.32M
1,031.90%
201K
99.40%
42.10M
20,843.28%
-409.72M
1,073.31%
-67.01M
83.65%
-9K
-
effect of forex changes on cash
-1K
-
-18K
1,700%
-48K
166.67%
258K
637.50%
-825K
419.77%
513K
162.18%
149K
70.96%
1.37M
820.81%
705K
48.62%
-961K
236.31%
-46K
95.21%
net change in cash
3.08M
-
50.09M
1,527.72%
33.72M
32.67%
-56.73M
268.22%
-2.56M
95.49%
-15.95M
523.83%
698.77M
4,482.38%
-477.23M
168.30%
-383K
99.92%
-79.68M
20,703.39%
42.72M
153.61%
cash at beginning of period
4.17M
-
7.24M
73.84%
57.33M
691.40%
91.05M
58.82%
34.32M
62.30%
31.77M
7.45%
15.82M
50.19%
714.59M
4,416.17%
237.37M
66.78%
236.98M
0.16%
157.31M
33.62%
cash at end of period
7.24M
-
57.33M
691.40%
91.05M
58.82%
34.32M
62.30%
31.77M
7.45%
15.82M
50.19%
714.59M
4,416.17%
237.37M
66.78%
236.98M
0.16%
157.31M
33.62%
200.02M
27.16%
operating cash flow
-8.91M
-
-11.70M
31.34%
-33.31M
184.68%
-46.02M
38.15%
-33.65M
26.87%
-16.54M
50.85%
-18.27M
10.48%
-65.15M
256.59%
69.44M
206.59%
-14.82M
121.35%
-18.73M
26.32%
capital expenditure
-59K
-
-1.40M
2,267.80%
-10.39M
643.88%
-13.91M
33.89%
-1.41M
89.90%
-122K
91.32%
-204K
67.21%
-3.73M
1,726.96%
-3.52M
5.42%
-585K
83.40%
-362K
38.12%
free cash flow
-8.97M
-
-13.10M
46.06%
-43.70M
233.66%
-59.93M
37.14%
-35.05M
41.51%
-16.66M
52.48%
-18.47M
10.90%
-68.88M
272.83%
65.92M
195.71%
-15.41M
123.38%
-19.09M
23.87%

All numbers in (except ratios and percentages)